Cancer Biology: Harvard University

Total Score People Score Events Score
710 306 162
Date Event Presentation Speakers
January 4, 2017 Innovations in Gastroenterology, 2017 Symposium A pathophysiologic approach to treating obesity: Michael Wolfe, USA Michael S. Wolfe
December 11, 2016 Cell-VIB Symposium: Hallmarks of Cancer [INV02] Nika Danial, Dana-Farber Cancer Institute, Harvard USA Auditorium Nika N. Danial
[KEY01] Lewis Cantley, Weill Cornell, USA Auditorium Lewis Cantley
November 7, 2016 Frontiers in Cancer Science 2016 LORENZ POELLINGER KEYNOTE TALK William G Kaelin
July 5, 2016 The 3rd Friends of Israel Urology Symposium (FOIU) The 3rd Friends of Israel Urology Symposium (FOIU) Venkatesh N Murthy
October 24, 2015 19th International Meeting of the European Society of Gynaecological Oncology (ESGO 2015) Parallel: Management of intermediate risk of endometrial cancer Michael J. Birrer
May 18, 2015 Next Generation Protein Therapeutics Dinner Discussions Alan C Rigby
April 10, 2015 Asian Oncology Summit 2015 Systemic therapy for cholangiocarcinoma: novel targets Andrew Zhu
Next generation of targeted therapy for NSCLC Pasi A Janne
Optimal management of metastatic hepatocellular carcinoma Andrew Zhu
April 7, 2015 World Vaccine Congress US 2015 HyperAcute® Immunotherapy: A Whole-Cell Vaccine Approach to Cancer Treatment Eugene Kennedy
December 5, 2014 24th World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists Current topics in translational GI oncology Carlos Fernández-del Castillo, Andrew Zhu
State-of-the-art imaging and genomics in oncology Dushyant Sahani
Abdominal malignancies - present reality and future perspectives for therapy 1 Gregory Lauwers
Abdominal malignancies - present reality and future perspectives for therapy 2 Gregory Lauwers
March 5, 2014 Targeted Anticancer Therapies Preclinical Models in the Development of Cancer Therapeutics Kwok-Kin Wong
February 17, 2014 Sao Paulo Advanced School in Oncogenesis and Translational Medicine (ESPCA) + Bioinformatics (Mini-course) Molecular-based classification of glioblastoma – Prof. Dr. Cameron Brennan Cameron W Brennan
January 30, 2014 Genitourinary Cancers Symposium General Session 3: Prostate Cancer- Tumor Board Audience Challenge (ARS) A. Oliver Sartor
General Session 5: Advances in Therapy for Urothelial Carcinoma Jonathan Rosenberg
January 6, 2014 AACR-IASLC Joint Conference on the Molecular Origins of Lung Cancer Concurrent Sessions 3-4 Kwok-Kin Wong
Plenary Session 4: EGFR Mutants in Lung Cancer: A 10-Year History Thomas J Lynch
Plenary Session 7: Advances in Molecular Targets and Novel Pathway-Based Therapy Bruce E. Johnson
November 14, 2013 2013 PQG Conference - Emerging Quantitative Issues in Disease Epigenetics Genome in 3D Leonid Mirny
November 11, 2013 Chromatin Structure and Function 2013 Robert Kingston Robert Kingston
October 27, 2013 Nature - CNIO Cancer Symposium: Frontiers in Tumour Heterogeneity and Plasticity Clinical and functional relevance of intratumor heterogeneity in breast cancer Kornelia Polyak
Targeting Clonal Heterogeneity and Signaling Networks in Myeloid Malignancies Ross Levine
October 6, 2013 Cell Symposia: Cancer Epigenomics Session 1: Cancer genomics, epigenomics, and epigenetic drivers Lynda Chin
June 19, 2013 Molecular Diagnostics for Cancer Drug Development Big Data + analytics = precision diagnoses and better outcomes Mark S Boguski
April 6, 2013 AACR Annual Meetings EPIGENETIC TARGETS FOR CANCER Anjana Rao, James E. Bradner
Developmental Origins of Cancer Chairperson: Richard J. Gilbertson, St. Jude Children's Research Hospital, Memphis, TN Stuart H. Orkin
Blood-Based Molecular Analysis of Cancer Daniel A Haber
Intrinsic and Microenvironment-Dependent Adaptive Responses that Regulate Drug Resistance Chairperson: Joan S. Brugge, Harvard Medical School, Boston, MA Joan S Brugge
The Interface Between Development and Cancer Using Model Organisms Chairperson: Michael M. Shen, Columbia University, New York, NY Leonard I. Zon
Emerging Single Cell Technologies in Cancer Research Chairperson: Garry P. Nolan, Stanford University School of Medicine, Stanford, CA Claude Lechene
Mutations in Epigenetic Regulators in Cancer Chairperson: Scott A. Armstrong, Memorial Sloan-Kettering Cancer Center, New York, NY Scott A. Armstrong
Mitotic Checkpoints Driving Cancer Therapeutic Strategies Chairperson: Peter K. Jackson, Genentech, Inc., South San Francisco, CA Timothy J Mitchison
Translational Control and Stress Response Pathways in Cancer Chairperson: Davide Ruggero, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Karen Cichowski
Developmental and Molecular Origins of Brain Tumors Co-Chairpersons: Suzanne J. Baker, St. Jude Children's Research Hospital, Memphis, TN, and Cameron W. Brennan, Memorial Sloan-Kettering Cancer Center, New York, NY Cameron W Brennan
Synthetic Lethality and Genetic Approaches to Cancer Chairperson: Stephen J. Elledge, Harvard Medical School, Boston, MA Stephen J Elledge
Structural Aberrations in a Thousand Tumors Chairperson: Raju Kucherlapati, Harvard Medical School, Boston, MA Raju Kucherlapati
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Anthony G. Letai
The Origins and Clinical Implications of Precancerous Lesions Chairperson: Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY Kornelia Polyak
Noncoding RNAs and Cancer Chairperson: Phillip A. Sharp, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA Jeannie T. Lee
New Cancer Vaccines Chairperson: Glenn Dranoff, Dana-Farber Cancer Institute, Boston, MA Glenn Dranoff
The Origins and Neoplastic Progression of Barrett's Esophagus Co-Chairpersons: Timothy C. Wang, Columbia University Medical Center, New York, NY, and Brian J. Reid, Fred Hutchinson Cancer Research Center, Seattle, WA Frank McKeon
Molecular Basis and Therapeutic Targeting of Bone Metastasis Co-Chairpersons: Yibin Kang, Princeton University, Princeton, NJ, and Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA Matthew Smith
Molecular and Cellular Determinants of Brain Metastasis Co-Chairpersons: William C. Hahn, Dana-Farber Cancer Institute, Boston, MA, and Joan Massagué, Memorial Sloan-Kettering Cancer Center, New York, NY Rakesh K Jain, William C Hahn
Avatar: Individualized Human Cancer Models in Mice Kwok-Kin Wong
Next-Generation Therapeutic Modeling in Mice Pier Paolo
The Utility of Cancer Cell Line Screens for Modeling Drug Sensitivities Moderator: Jeffrey Settleman, Genentech, Inc., South San Francisco, CA Levi A Garraway
Clinical Trials Based on Mutations versus Histology William R Sellers, Lewis C Cantley
Human Papillomavirus: Beyond Cervical Cancer Chairperson: Maura L. Gillison, The Ohio State University Comprehensive Cancer Center, Columbus, OH Peter M Howley
From Chemistry to the Clinic: Pathways for Drug Discovery and Development, Part 1: Targeting Mechanisms of Therapeutic Resistance Chairperson: Matt V. Lorenzi, Janssen Research & Development, Spring House, PA Kwok-Kin Wong
Credentialing Response Biomarkers for Signal Transduction Inhibitors Chairperson: Neal Rosen, Memorial Sloan-Kettering Cancer Center, New York, NY Anthony G. Letai
Therapeutic Nanotechnology Chairperson: Gregory Lanza, Washington University, St. Louis, MO Omid C Farokhzad
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Scott A. Armstrong
The Next Frontier in Targeted Therapy for Melanoma Chairperson to be announced Lynda Chin
New Paradigms in Molecular Pharmacology Chairperson: Angela N. Koehler, Broad Institute of MIT and Harvard, Cambridge, MA James E. Bradner
Metabolism and Signaling in Cancer Chairperson: Eyal Gottlieb, The Beatson Institute for Cancer Research, Glasgow, United Kingdom Nika N. Danial
Immune Modulation in the Tumor Microenviroment Chairperson: James P. Allison, Memorial Sloan-Kettering Cancer Center, New York, NY Raghu Kalluri
Cancer Imaging in Mice and Men Andrew L. Kung, Dana-Farber Cancer Institute, Boston, MA Andrew Kung
2-Oxoglutarate-Dependent Dioxygenases as Targets of Cancer-Causing Mutations and Cancer Therapeutics William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, MA William G Kaelin
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY Xandra O Breakefield
Autocrine Activation of MET and Strategies to Overcome Adaptation for the Targeted Therapy of Acute Myeloid Leukemia A. Thomas Look, Dana-Farber Cancer Institute, Boston, MA Thomas A. Look
Stapled Peptides as Next-Generation Therapeutics Gregory L. Verdine, Harvard University, Cambridge, MA Gregory L Verdine
Prognostic and Predictive Biomarkers of Triple-Negative Breast Cancer Andrea L. Richardson, Brigham and Women's Hospital, Boston, MA Andrea L Richardson
Cancer Omics Beyond the Genome Sunney Xie
16th Annual Grant Writing Workshop Building Presence and Leadership through Empowered Communication Co-Chairpersons: Martine J. Piccart, Institut Jules Bordet, Brussels, Belgium, and Victoria M. Richon. Epizyme, Inc., Wellesley Hills, MA Kornelia Polyak
Patient-Derived Xenograft Models of Cancer: Where Are We Going? Chairperson: Matthew J. Ellis, Washington University Siteman Cancer Center, St. Louis, MO Tan Ince
WICR Career Mentoring Session Joan S Brugge
January 31, 2013 5th Immunotherapeutics & Immunomonitoring KEYNOTE PRESENTATION Jeffrey J. Popma
January 20, 2013 Tumor Invasion and Metastasis GEM models in translational research Lynda Chin
Regulation of metastasis via tumor-stromal interactions Randolph S Watnick
Session 8: Treatment of Metastatic Cancer Bruce R. Zetter
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Regenerative Medicine David T Scadden
Career-Development Lunch Sessions D. Gary Gilliland, Daniel J. DeAngelo, David Avigan, Ellis J. Neufeld
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium Mini-Symposium 1 - The mTOR pathway: Role in Metabolism and as a Therapeutic Target - Exhibit Hall D Lewis Cantley
September 13, 2012 International Society of Gastrointestinal Oncology Transarterial Embolic Therapy for Liver-Predominant NETs: Bland vs. Chemoembolization vs. Radioembolization David R Liu
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer Group B Van Transportation to GRB Training Lab | Workshop: (Group B) Pathology, Tissue Trimming, and Necropsy Paul Doty
Pathology and histopathology of normal and neoplastic tissue: an overview Paul Doty
EGFR Pathways and Cancer Pasi A Janne
Modeling the Ras Pathway in Cancer Karen Cichowski
Mouse Cancer Models for Targeting PI 3-K Lewis Cantley
Personalized medicine Raju Kucherlapati
Tumor Angiogenesis And Microenvironment Rakesh K Jain
Zebrafish Models to Dissect Human Cancer Pathways Thomas A. Look
February 9, 2012 Dermatogenetics Roles for MITF in melanomagenesi David E Fisher
January 8, 2012 Noncoding RNAs and Cancer X-inactivation, RNA, stem cells, and cancer Jeannie T. Lee
Mechanism of RNAi-mediated heterochromatin assembly Danesh Moazed
Session 2 | Chromatin Modifications Danesh Moazed
Session 1 | Long Noncoding RNAs Jeannie T. Lee
Functional genomics, small RNAs, and cancer William C Hahn
Session 7 | RNA in Cancer and Disease William C Hahn
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Welcome and Opening Remarks Judy Garber
Epigenetics of hormone dependence Myles Brown
December 9, 2011 2nd Oxford Symposium on Epigenetic Mechanisms in Health and Disease Session 1 | An epigenetic switch linking inflammation to cancer Kevin Struhl
November 18, 2011 16th Annual Perspectives In Thoracic Oncology Role of EGFR TKIs as frontline therapy in mutation positive patients with NCSLC Lecia Sequist
EML4/ALK and other new biomarkers and their therapeutic implications Lecia Sequist
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Changing cell fate in cancer: Lessons from melanoma Leonard I. Zon
Predicting response and resistance to targeted anticancer therapeutics Levi A Garraway
Concurrent Session 4 | Somatic driver mutations as a guide for anticancer treatment in lung cancer Bruce E. Johnson
Concurrent Session 2 | Functional genomics to identify targets and resistance William C Hahn
Concurrent Session 2 | Mechanism-based Targeted Combination Therapies William C Hahn
Concurrent Session 1 | Identifying druggable targets from alterations in the cancer genome Matthew Meyerson
Engineering improved cancer vaccines Glenn Dranoff
Concurrent Session 7 | Title to be announced Lynda Chin
Concurrent Session 7 | Challenges in Genomic-based Characterization of Tumors Lynda Chin
November 11, 2011 IBD 2011: Progress and Future for Lifelong Management Role of innate immunity on IBD pathogenesis Ramnik J. Xavier
Translating the new IBD genetics into therapy Stuart Schreiber
October 20, 2011 Nature Chemical Biology Symposium 2011: Cancer Chemical Biology Relating genetic features of human cancers to smallmolecule drug efficacies Stuart Schreiber
Welcome and Opening Remarks Gregory L Verdine
Bromodomain inhibition in cancer James E. Bradner
Introduction Ralph Mazitschek
Introduction Andrew Kung
Targeting metabolic enzymes for cancer therapy Lewis Cantley
Closing Remarks Gregory L Verdine
October 16, 2011 the 15th annual Update and Review of Internal Medicine 2011 welcome and Introduction Martin J Abrahamson
Endocrinology Q & A Martin J Abrahamson
A practical Approach to the diagnosis and Management of Thyroid disease Martin J Abrahamson
New drugs for the pcp 2011 | what You Need to Know Gerald W. Smetana
panel discussion Gerald W. Smetana
Treatment of Type 2 diabetes 2011 | Update Martin J Abrahamson
Hypertension | New Strategies for Your practice Gerald W. Smetana
Oncology | challenging cases with Your participation Lowell E Schnipper
Oncology Q & A Lowell E Schnipper
cancer | From the Bench to the Bedside Lowell E Schnipper
October 2, 2011 31st Annual Oncology Nurses Symposium Early Palliative Care Constance Dahlin
September 30, 2011 Revisiting IBD Management: Dogmas to be Challenged Wrap-up Stuart Schreiber
Dogma 6 – Innovative treatments will offer a better outcome for patients with IBD Stuart Schreiber
Can we slow down evolution from early to late CD? Stuart Schreiber
September 11, 2011 Stem Cells in Development and Disease Stem Cells in Development and Disease Stuart Orkin, Konrad Hochedlinger, Leonard I. Zon, George Daley
August 31, 2011 Strategies for Engineered Negligible Senescence, 5th Conference (SENS5) Tissue engineering of the lung using decellularised scaffolds Loren Niklason
August 20, 2011 20th Annual Short Course on Experimental Models of Human Cancer Tumor Angiogenesis And Microenvironment Rakesh K Jain
Modeling the Ras Pathway in Cancer Karen Cichowski
Zebrafish Models to Dissect Human Cancer Pathways Thomas A. Look
EGFR Pathways and Cancer Pasi A Janne
Personalized medicine Raju Kucherlapati
ROUND TABLE - PANEL OF EXPERTS - FORUM OF OPEN DISCUSSION WITH ATTENDEES | Monotherapies or combined therapeutics? Clinically addressing the complexity of molecular pathways in cancer: How can we develop the most relevant combination beyond individual Pharma/Biotech pipelines: a risk sharing approach for the benefit of the patient D. Gary Gilliland
Predicting efficacy of therapeutics in clinical trials | filling the gap between pre-clinical models and phase I clinical trials D. Gary Gilliland
New targets and innovative therapeutics Kenneth C Anderson
June 20, 2011 Changing Landscape of the Cancer Genome (F3) Somatic Genome Alterations in Human Lung Cancer Matthew Meyerson
GBM Lynda Chin
Characterizing the Prostate Cancer Genome Levi A Garraway
Talk Title to be Determined Richard Wilson
Protein Interactome Marc Vidal
June 20, 2011 Cancer Proteomics 2011 - Systems Biology, Developmental Models and Data Integration Interactome networks & human disease Marc Vidal
May 26, 2011 Idibell Cancer Conference on Metastasis and Angiogenesis Tumor microenvironment controls the rate of metastasis Raghu Kalluri
May 18, 2011 SBI 10th Postgraduate Course Challenging Cases MRI (Audience Response System) Sughra Raza
Gerald Dodd Lecture | Biology Of Breast Cancer Stuart J Schnitt
May 2, 2011 LIPID MAPS Annual Meeting 2011: Lipidomics Impact on Cell Biology, Cancer, and Metabolic Diseases Mechanisms and targets of Leukotriene E4 in pulmonary inflammation Joshua A. Boyce
PI 3-Kinase, metabolism and disease Lewis C Cantley
April 29, 2011 8th CURRENT TRENDS IN AORTIC AND CARDIOTHORACIC SURGERY Worldwide Experience with TAVI Clinical Trials: Where Are We? Jeffrey J. Popma
April 4, 2011 RNAi & Single Cell Biology-2011 Summit Single Cell Biology: From Single Molecule spectroscopy, optical imaging to gene expression living cells Sunney Xie
TBA Francisco Navarro
Single Cell Biology: From Single Molecule spectroscopy, optical imaging to gene expression living cells Sunney Xie
March 27, 2011 Autophagy (D1) Workshop 2: Autophagy and Disease: A Clinical Point of View Ramnik J. Xavier
Homeostatic connection between the Unfolded Protein Response (UPR) and autophagy in neurodegeneration. C Hetz
Integrative Genomics Approaches to Gene Discovery in Autophagy and Disease Ramnik J. Xavier
March 25, 2011 Eighth International Symposium on Ovarian Cancer and Gynecologic Malignancies New Agents and Translational Research Michael J. Birrer
March 20, 2011 AAA and Related ATP-Driven Protein Machines: Structure, Function and Mechanism (C6) Assembly and Function of the Hetero-hexameric AAA ring of the Proteasome Daniel Finley
March 6, 2011 Stem Cells, Cancer and Metastasis (C4) Genes that Regulate Migration and Invasion Joan S Brugge
Molecular characterization of circulating tumor cells Daniel A Haber
Stem Cells in Normal Lung and Lung Cancer Carla Bender Kim
Roundtable: Cancer Stem Cells in Metastasis: Insights and Controversies Daniel A Haber
March 3, 2011 Stem Cells, Development, and Cancer Dissecting the mechanisms of cellular reprogramming Konrad Hochedlinger
Reversible tolerance to anticancer drugs Jeffrey Settleman
March 1, 2011 "The Latest Advances in Liver Cancer Research: From Basic Science to Therapeutics" Session 3 | (title will be announced later) Sonia Friedman
Sessions 3 | (title will be announced later) Sonia Friedman
February 27, 2011 Signal Transduction within the Nucleus Gordon Research Conference Control of chromosome organization and stability by inner nuclear membrane proteins Danesh Moazed
February 24, 2011 Targeting P13K / mTOR Signaling in Cancer Keynote Session Lewis C Cantley
Strategies for targeting the PI3K pathway when employing combination therapies Jeffrey Adam Engelman
The TSC-mTOR pathway regulates tumor cell metabolism downstream of PI3K Brendan Manning
PI3-Kinase and cancer cell metabolism Lewis C Cantley
Session 1 | PI3K/mTOR Signaling Lewis C Cantley
Targeting PI3K isoforms in cancer Jean J Zhao
Session 5 | Late-Breaking Research / Hot Topics Lewis C Cantley
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Primary Central Nervous System Lymphoma Tracy T Batchelor
Management of Autoimmune Issues in Chronic Lymphocytic Leukemia Jennifer R. Brown
Comment Jennifer R. Brown
CDK Inhibitors Noopur Raje
PI3K | Akt Pathway Inhibitors Jennifer R. Brown
BCR | Downstream Therapeutic Targets Jennifer R. Brown
Aggressive Lymphoid Malignancies (Acute Lymphoblastic Leukemia, Lymphoblastic Leukemia, Burkitt Lymphoma) Daniel J. DeAngelo
Outlook for Management of Bone Disease in Multiple Myeloma Noopur Raje
Multiple Myeloma Noopur Raje
Acute Myeloid Leukemia | Myelodysplastic Syndromes Daniel J. DeAngelo
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Adaptive Immunity against Cancer? | Mechanisms of Protective Tumor Immunity Glenn Dranoff
February 6, 2011 Miami 2011 Winter Symposium: Epigenetics in Development and Disease Session 2 | Three-dimensional chromatin networks and chromosome folding Job Dekker
Session 5 | Engineering models of epigenomic transformation Tan Ince
RNAi-mediated heterochromatin assembly and propagation Danesh Moazed
February 6, 2011 Salivary Glands & Exocrine Biology Neural regulation of lacrimal gland signaling and secretion Darlene A Dartt
Inflammation and Autoimmunity Darlene A Dartt
January 12, 2011 "Nano in Cancer": Linking Chemistry, Biology, and Clinical Applications In Vivo Session 3: Biomarkers and Diagnostics Ralph J Weissleder
Cancer cell profiling with DMR Ralph J Weissleder
January 10, 2011 Histone Code: Fact or Fiction? (A6) Investigating the Mechanism of Inheritance of Polycomb Group proteins through DNA Replication in vitro. | Matterhorn Ballroom Nicole J. Francis
Histone Modifications in Heterochromatin Assembly and Propagation | Matterhorn Ballroom Danesh Moazed
Three-Dimensional Organization of Chromosomes | Matterhorn Ballroom Job Dekker
Histone Demethylation | Matterhorn Ballroom Yang Shi
December 8, 2010 33rd Annual CTRC-AACR San Antonio Breast Cancer Symposium DNA Repair | Ballroom C-3 Daniel P. Silver
DNA repair and breast cancer: Therapeutic opportunities and challenges Daniel P. Silver
Measuring and modeling cell death pathways in tumor cells Peter K. Sorger
Panel Discussion Judy E Garber
Clinical Science Forum - Controversies in Screening for Breast Cancer | Ballroom A Eric P. Winer
The role of providers in breast cancer disparities Nancy L. Keating
November 18, 2010 IV Congress of the International Society of Nutrigenetics/Nutrigenomics ISNN Modulation of inflamatory cytokines by omega-3 fatty acids Jing X Kang
Public health programs based on poblational omics studies Frank B. Hu
November 8, 2010 Cancer Metabolism A novel mechanism for regulation of AMPK activity in response to nutrients and hormones Barbara Kahn
PI 3-kinase and glucose metabolism Lewis C Cantley
Novel targets for Lkb1-deficient metastatic lung tumors Kwok-Kin Wong
The control of cellular metabolism downstream of mTOR complex 1 Brendan Manning
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research PARP inhibitors: Early promise in breast and ovarian cancer prevention Judy E Garber
Clinical trials in neurofibromatosis 1 and 2 Scott Plotkin
November 7, 2010 Frontiers of Immunology in Health and Diseases Frontiers of Immunology in Health and Diseases Diane Mathis
November 4, 2010 Advances in Cancer Management for the Surgeon Interesting Case Presentations and Panel Discussion RICHARD SWANSON
Management of Cystic Neoplasms of the Pancreas: Surgery Vs. Observation RICHARD SWANSON
Total Mesorectal Excision (TME) for Rectal Cancer James C. Cusack
Community Tumor Board: Case Presentations Drawn from the Audience James C. Cusack, David Ryan
Interesting Case Presentations and Panel Discussion James C. Cusack
Banquet Luncheon and Interesting Case Presentations Michelle Gadd
Challenges in Pre-operative Therapy for Breast Cancer Michelle Gadd
Current Management of DCIS, ADH and LCIS Michelle C. Specht
Controversies in Local Management of Breast Cancer Barbara Smith
Interesting Presentations and Panel Discussion James C. Cusack
October 27, 2010 Colorectal Cancer: Biology to Therapy Molecular imaging approaches to colorectal cancer Umar Mahmood
October 19, 2010 Colon Cancer in Murine Models and Humans III SESSION 3: Genome (in)stability (CIN and MIN) and epigenetic factors (CIMP): The multiple pathway hypothesis; somatic mutations and epimutations | Bar Harbor Club Ballroom Shuji Ogino
SESSION 5: Inflammation and environmental risk factors; intestinal flora; chemoprevention | Bar Harbor Club Ballroom Monica M. Bertagnolli
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities From genomics to personalized medicine in oncology Levi A Garraway
Title to be announced Deborah Schrag
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved From genomics to personalized medicine in oncology Levi A Garraway
September 27, 2010 Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development Plenary Session 1: Transformative Technology: Large Scale Profiling Jeffrey Settleman
Plenary Session 5: Molecular Prediction, Classification, and Prognostic Markers David J Hunter
Plenary Session 4: Hurdles to Molecular Diagnostics Development and Implementation Mehmet Toner
September 27, 2010 25th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and Metastasis: from Bench to Bedside to Biomarkers Opening Remarks Rakesh K Jain
Tumor Microenvironment I: Angiogenesis and Vascular Transport Rakesh K Jain
Normalization of Tumor Vasculature and Microenvironment by Antiangiogenic Therapy: from Bench to Bedside to Biomarkers Rakesh K Jain
Tumor Microenvironment II: Interstitial and Lymphatic Transport Rakesh K Jain
Tumor Stroma Generation: Role of VPF/VEGF Harold F. Dvorak
Mining the Human Proteome: Biomarker Discovery for Human Cancer and Its Metastases Marsha Moses
Genetics in Cancer Therapy Raju Kucherlapati
Imaging Angiogenesis and Vascular Function in Cancer Patients A. Gregory Sorensen
September 25, 2010 The Management of Women with Chronic Immune Disorders in the Era of Biologics Q&A with panel discussion: Maintaining health and quality of life Sonia Friedman, Alexa Boer Kimball
Quality of life and social connectivity for women: A comparison across immune disorders Alexa Boer Kimball
Healthcare maintenance for immune disorders: An update on vaccinations, bone monitoring, and cancer screening Sonia Friedman
Q&A with panel discussion: Are children just little adults? Daniela Kroshinsky
The Young and the Restless: A case-based approach to growth, medication risk, and transition of care Daniela Kroshinsky
Summary and concluding remarks Alexa Boer Kimball
Q&A with Panel discussion: Managing patient’s expectations on pregnancy Sonia Friedman
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Seed and soil hypothesis revisited Rakesh K Jain
Keynote Address | Title to be announced Joan Brugge
Welcome Bruce R. Zetter
August 23, 2010 The Ubiquitin Drug Discovery & Diagnostics Conference Proteomic and informatic approaches in the study of the Ubiquitin Pathway Wade Harper
Keynote Address Alfred L. Goldberg
Inhibition of proteasomal deubiquitinating enzyme Usp14 Daniel Finley
Targeting Protein Degradatation as a Therapeutic Strategy in Myeloma Kenneth C Anderson
July 11, 2010 Translational Cancer Medicine 2010 (USA) Drugging “undruggable” transcriptional targets Gregory L Verdine
Novel strategies for drug development in oncology D. Gary Gilliland
Comprehensive genomic approaches to identify cancer targets William C Hahn
Modeling drug sensitivity and resistance in human tumor-derived cell lines Jeffrey Settleman
Functionalizing the cancer genome Lynda Chin
Title to be announced Levi A Garraway
Altered nutrient requirements in cells with activated mTOR complex 1 John Blenis
Title to be announced Shyamala Maheswaran
Title to be announced George Daniel Demetri
July 4, 2010 The Multiple Tiers of Gene Regulation in Cancer Systems William C Hahn
June 23, 2010 Structure-Based Drug Design In Silico Discovery of Small Molecule Transcription Factor Inhibitors Alan C Rigby
Chairperson’s Remarks Alan C Rigby
June 20, 2010 Human Variation: Cause and Consequence Disease Genetics | Mark Daly Mark Daly
Phenotypic consequences of variation in human genome structure Steven McCarroll
June 14, 2010 Development and Stem Cells in the Pancreas Insulin Signaling and the Pathogenesis of Diabetes C. Ronald Kahn
June 6, 2010 The Future of Molecular Epidemiology: New Tools, Biomarkers, and Opportunities Welcome and Keynote Session: Where is Molecular Epidemiology? David J. Hunter
May 19, 2010 Towards Personalized Cancer Medicine New Cancer Targets Emerging From Studies of the von Hippel-Lindau Tumor Suppressor Protein William G Kaelin
Functionalizing the Cancer Genome Lynda Chin
SESSION III: Oncogenomics and Tumor Profiling Lynda Chin
Target and Drug Discovery in Oncology: The Right Drug for the Right Patient D. Gary Gilliland
May 3, 2010 LIPID MAPS Annual Meeting 2010: Lipidomics Impact on Cell Biology, Atherosclerosis and Inflammatory Disease Foam cells and immunology of obesity Steven Shoelson
April 30, 2010 Drug Story KEYNOTE PRESENTATION Joshua LaBaer
April 6, 2010 IBCs 5th Annual China 2010 Pharmaceutical R&D Summit China's Healthcare Reform: Implications for the Industrial Sectors Yuan-Li Liu
March 13, 2010 Cancer, Medical Malpractice and Primary Care: Improving Skills and Lessening Risks Closing Remarks and Evaluation MARC B. GARNICK
Case Studies of Medical Malpractice in Lung Cancer and Decision Support Tools MARK HUBERMAN, PAUL SPIRN
Considerations for the Primary Care Physician Related to Lung Cancer Screening, Evaluation and Reporting of Pulmonary Radiographs PAUL SPIRN
Case Studies of Medical Malpractice in Prostate Cancer and Decision Support Tools MARC B. GARNICK, MICHAEL J. BARRY, KEVIN LOUGHLIN
Considerations for the Primary Care Physician Related to Prostate Cancer Screening MICHAEL J. BARRY
LUNCH AND PRESENTATION: Experiencing a Medical Malpractice Claim: A Physician’s Perspective ELIZABETH CUSHING
Case Studies of Medical Malpractice in Breast Cancer and Decision Support Tools Lowell E Schnipper, JENNIFER POTTER, SUSAN TROYAN, NADINE TUNG
Genetic Counseling NADINE TUNG
Considerations for the Primary Care Physician Related to Breast Cancer Screening and Mammographic Follow‑up SUSAN TROYAN
Case Studies of Medical Malpractice in Colorectal Cancer and Decision Support Tools HELEN SHIELDS
Considerations for the Primary Care Physician Related to Colorectal Cancer Screening HELEN SHIELDS
Welcome and Course Introduction MARC B. GARNICK
December 4, 2009 2009 Advances in Inflammatory Bowel Diseases Positioning biologics in ulcerative colitis | 1 Bruce E. Sands
Unanswered research questions in microbiology of IBD | 2 Ramnik J. Xavier
Unanswered research questions in microbiology of IBD| 2 Ramnik J. Xavier
Functional roles of autophagy genes in IBD| 2 Ramnik J. Xavier
Session VIII A: Advances in the management of IBD – II Robert Burakoff
November 19, 2009 Stem Cells 2009 Regulation of micoRNA biogenesis in stem cells and cancer Richard Gregory
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Keynote Lecture: Pursuing Placebo: From Noise to Signal Ted Kaptchuk
October 23, 2009 Current Topics in Surgery The Johann Ehrenhaft Lecture: Evolution of the treatment of mitral valve disease Lawrence Cohn
September 24, 2009 Track 3:Advancing Cancer Therapy : Inaugural Circulating Tumor Cells Genome-Subtractive Cancer-Specific Blood Assay Amin L Kassis
September 23, 2009 Track 3: Advancing Cancer Therapy : Second Annual Translational Cancer Medicine The Use of Genetically Engineered Mice for Preclinical Testing of Novel Cancer Therapeutics Kwok-Kin Wong
September 21, 2009 Next-Generation Sequencing Data Analysis KEYNOTE PRESENTATION 1 John Quackenbush
September 21, 2009 Third Annual Exploring Next Generation Sequencing Targeted Sequencing of Human Genomes, Transcriptomes and Methylomes Jin Billy Li
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery The chemical biology of behavior and psychiatric disease Randall Peterson
Drugging the "undruggable" Gregory Verdine
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems Agonists of Pattern Recognition Receptors, including TLRs and NLRs, as Vaccine Adjuvants: Current Practice and Translational Development Ofer Levy
DNA Vaccines for HIV-1 Dan H Barouch
August 10, 2009 Second Annual Trends in Cancer Diagnostics EGFR and Beyond: Evolution of a Molecular Classification and Treatment Strategy for Lung Cancer Neal Lindeman
August 5, 2009 New Frontiers in Cancer Drug Development A New Paradigm for Translational Cancer Research: Targeting Endocrine Factors and Real Human Tumors Sandra S. McAllister
Turning Cancer Sequencing Data into Therapeutic Targets Heidi Greulich
Combinations of Novel and Conventional Cancer Agents: Challenges and Opportunities Kenneth C Anderson
The Use of Genetically Engineered Mouse Lung Cancer Models to Assess Effectiveness of Targeted Therapeutic Combinations Kwok-Kin Wong
The Evolving Treatment Paradigm in Multiple Myeloma Kenneth C Anderson
August 5, 2009 Targets in Context - Linking Targets to Diseases Agenda Michael Foley, Ph.D. Build-Couple-Pair Strategy for Diversity-Oriented Synthesis Yields a Unique Compound Collection for Probe Development and Drug Discovery Michael Foley
In Vivo Chemical Screening in Zebrafish Joanna Yeh
June 8, 2009 RNAi for Functional Screens Talk Title to Be Announced Caroline Shamu
February 19, 2009 HKEC Training Centre for Healthcare managment & Clinical Techology Update on imaging techniques and Chemotherapy for colorectal cancer John LEUNG
February 7, 2009 Translation of the Cancer Genome CONCURRENT EDUCATION SESSIONS Ronald A DePinho, John Quackenbush
February 5, 2009 ACI’s National Conference on Successful Strategies For Genetic AN D Molecular Diagnostic Testing SPONSORS 2:15 PM - 3:15 PM The role of Molecular diagnostic testing in managing patients with lung adenocarcinoma Neal Lindeman
How to build a successful molecular diagnostics laboratory Gyorgy Abel
January 21, 2009 Advances in Prostate Cancer Research SESSION 2: PTEN Pier Paolo, Levi A Garraway
January 12, 2009 Mouse Models of Cancer SESSION 2: GENOMICS Ronald A DePinho
December 11, 2008 SAN ANTONIO BREAST CANCER SYMPOSIUM Breast cancer stem cells: in search of definitions, markers, and clinical relevance Kornelia Polyak
December 7, 2008 AMERICAN SOCIETY FOR MATRIX BIOLOGY 2008 Meeting SIG 1: Syndecan1 Shedding: An Innate Immune Response to Infection Pyong Woo Park
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) TBD Yu-Li Wang
Co-Chair :Track 2-8 Zhen Y. Jiang
Analyzing Insulin Signaling Networks and Metabolic Functions Using Quantitative Proteomics Approach :Track 2-8 Zhen Y. Jiang
Oral Delivery of Glucan Encapsulated siRNA to Macrophages Targeting Map4K4 Attenuates Systemic Inflammation :Track 2-8 Myriam Aouadi
Developmental Origin of Adipose Tissue: Novel Role of Bone Morphogenetic Proteins in Adipogenesis and Energy Metabolism :Track 2-8 Yu-Hua Tseng
Title: TBD : Track 4-4 Jing X. Kang
November 12, 2008 Invited Session, SESSION 5 – Using DNA Sequence to Detect Variation Related to Human Disease: The Promises and Challenges of Medical Sequencing Introduction S B Gabriel
New technologies for medical sequencing: 1000 Genomes and other stories S B Gabriel
November 4, 2008 The Chemotherapy Foundation Symposium XXVI OR Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow EASING OF SUFFERING IN CHILDREN WITH ADVANCED CANCER Joanne Wolfe
October 31, 2008 Changing Paradigms in Lung Cancer Care and Advances in the Pipeline Therapeutic Workshop Thomas J Lynch
October 30, 2008 44th ASCO Annual Meeting General Session I: Minimal Residual Disease and Circulating Tumor Cells Lecia Sequist
General Session II: Identifying Patients for EGFR Inhibitor Therapy: Markers of Response and Resistance Bruce E. Johnson
General Session II: Identifying Patients for EGFR Inhibitor Therapy: Markers of Response and Resistance (continued Pasi A Janne
General Session IV: Molecular Markers of Response and Resistance to Angiogenesis Inhibitors Tracy T Batchelor, Rakesh K Jain
Organizing Commitee Bruce E. Johnson
Scientific Commitee Bruce E. Johnson
October 21, 2008 20th EORTC - NCI - AACR Symposium on "Molecular Targets and Cancer Therapeutics" Plenary session 3 Proteasome Kenneth C Anderson
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Resolvins and Protectins : Anti-inflammatory and Pro-resolving Actions of Omega-3 Fatty Acid-derived Mediators Matthew Spite
September 29, 2008 Stem Cells, Cancer and Aging (S3) New Targets and Therapeutic Approaches to Cancer and Aging Gregory L Verdine
September 5, 2008 44th ASCO Annual Meeting General Session I: Risk, Screening, and Prevention Judy E Garber
General Session IV: Triple-Negative Breast Cancer: What's Positive? Andrea Richardson, Daniel Silver
General Session V: Selected Controversies in Pathology Stuart J Schnitt
General Session VII: Challenges in Survivorship Ann H Partridge
General Session X: Multidisciplinary Implications of Preoperative Therapy Susan C Lester
August 13, 2008 Advances In Cancer Vaccines Dendritic Cell Tumor Fusions from the Bench to the Bedside David Avigan
Unique Vaccine Adjuvant Efficacy of Toll-like Receptor 8 (TLR8) Agonists that Activate Human Antigen-Presenting Cells Ofer Levy
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Proof of Concept to Pre-Clinical Scientist George Daniel Demetri
May 30, 2008 44th ASCO Annual Meeting Program Committee Daniel Chung
Planning Committee Steven Joffe
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
breast cancer-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer genetics-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer genetics-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
cancer prevention/epidemiology-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
cancer prevention/epidemiology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
central nervous system tumors-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
clinical trials-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
ethics-- Early Data: Presenting and Publishing Preliminary Results Donna S. Neuberg
gastrointestinal (noncolorectal) cancer-- Gastrointestinal Stromal Tumor (GIST) Comes of Age: Current Management Using Molecular Pathology, Surgery, and Targeted Therapy George Daniel Demetri
geriatric oncology--Adjuvant Chemotherapy of Breast Cancer: Do We Still Need Anthracyclines? Eric P. Winer
lung cancer-- Targeted and Novel Agents in Small Cell Lung Cancer Bruce E. Johnson
melanoma/skin cancers-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
patient and survivor care-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
patient and survivor care-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
patient and survivor care-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
pediatric cancer-- Molecular Pathways of Cancer Predisposition in Children, Adolescents, and Young Adults Lisa Diller
pediatric cancer-- Challenges and Optimizing Outcomes in Adolescents and Young Adults with Cancer Karen H. Albritton
pediatric cancer-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
pediatric cancer-- Melanoma in Children, Adolescents, and Young Adults David E Fisher
sarcoma/bone and soft tissue cancers-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
sarcoma/bone and soft tissue cancers-- Treatment Approaches and Functional Outcomes in Pediatric Sarcomas Mark Gebhardt
tumor biology-- Predicting and Targeting Drug Resistance to Tyrosine Kinase Inhibitors Jeffrey Adam Engelman
meet the professor sessions-- New Models for Survivorship Care Programs (M15) Lawrence N. Shulman
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10A) Patrick Y. Wen
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14A) Judy E Garber
clinical problems in oncology-- Recognition and Management of Patients with Inherited Risk of Breast Cancer (CPO14B) Judy E Garber
clinical problems in oncology-- Managing the Medical Complications of Patients with Brain Tumors (CPO10B) Patrick Y. Wen
April 28, 2008 Clinical Development of Therapeutic Antibodies Normalizing Tumor Vessels and Microenvironment to Treat Cancer: From the Bench to Bedside and Back Rakesh K Jain
March 25, 2008 PATHWAY ANALYSIS Chairperson’s Remarks Tara M Love
Not miR-ly Small RNAs: Genetic Approach to Defining microRNA Pathways Tara M Love
March 25, 2008 CANCER MOLECULAR MARKERS Therapeutic Potential of Targeting microRNAs in Chronic Myeloid Leukemia Tara M Love
Chairperson’s Remarks Tara M Love
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic Title to be announced William G Kaelin
Clinical Targeting and Inhibition of Tyrosine Kinases in GIST and Sarcomas: Lessons for Cancer Therapy and Future Directions George Daniel Demetri
RNAi, NON-CODING RNA, AND microRNA William C Hahn
Functional Genomics, Experimental Models, and Cancer William C Hahn
March 9, 2008 DNA DAMAGE, MUTATION & CANCER IgH Class Switching, DNA End-Joining, Translocation, and Cancer Frederick Alt
March 4, 2008 Maintenance of Genome Stability Conference 2008 Session 5: DNA repair and genome stability (Chair: Jiri Lukas) Alan D Andrea
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE New directions in adipocyte development Evan Rosen
February 17, 2008 GRC - Glycolipid & Sphingolipid Biology Arrival and Check-in (Office Closed 6:00 pm - 7:45 pm) Test User
Cell non-autonomous function of ceramidase in photoreceptor homeostasis Usha Acharya
February 12, 2008 NF-kappaB NF-kappaB Signaling in the Innate Immune System Martin E. Dorf, Michelle A. Kelliher
February 3, 2008 AACR - Cytoskeletal Signaling in Cancer SESSION 3: MATRIX PROTEINS IN CANCER Lucia R. Languino
January 18, 2008 Translational Research Program Stem Cell Symposium Circulating Endothelial Cells Dan G Duda
December 13, 2007 Stem Cells 2007 TBC David T Scadden
December 1, 2007 47TH American Socieity of Cell Biology Design Principles for Connecting the Genome to the World I Philips, C. Ajo-Franklin
Minisymposium 1A:Cell Biology Working Group: Challenges in Cell Biology—The Nature of Cytoplasm Timothy J Mitchison
Interphase and Mitotic CDKs Follow Kinetically Distinct Paths to Activation in Human Cells. C. Zhang
*Single-Molecule Analysis Reveals the Distribution of Potential vs. Active DNA Replication Origins in Human Cells R. Lebofsky
Cell Matrix Interactions (Room 140A) Yu-Li Wang
Advances in Bone Cell Molecular Biology: Epigenetic Control Jane Lian, Gary S Stein
CLASPs Clutching Microtubule Networks (Room 209 B/C) David Van Vactor
At the Limits: Optical Methods for Single Molecules, Cells, and Organisms Jennifer Waters, Samara Rech-Peterson
High Performance Image Analysis and Photomanipulative Techniques for Jeffrey Nickerson
Building the Cell (Room 140B) L Mahadevan
Systems Biology of Receptor Tyrosine Kinase Networks (Room 206) Peter K. Sorger
Public Service Award Presentation Matthew Michael
Primary Role for Centrosome Proteins in Cilia Formation and Cilia-associated Disorders B Delaval, L Covassin Barberis, N Lawson, Stephen J Doxsey
Cell-Type Variation in Responses to Anti-mitotic Drugs. C Loy, J Orth, C Shamu, M Tsui, V Yanamadala, Timothy J Mitchison
Fluorescence Correlation Spectroscopy Workshop Daniel Needham
Actin Disassembly by Whole-Filament Destabilization.v H Kueh, W M Brieher, Timothy J Mitchison
How Does Thrombospondin Induce CNS Synaptogenesis? J. T. Lawler
Identifying Matrix- and Growth Factor-induced Transcriptional Dichotomies by Stochastic Sampling. K A Janes, Joan Brugge
High-Tech Cell Biology Kendall Knight
DNA Damage Signaling Events Revealed by 4Pi Microscopy. Kendall Knight, Brian T Bennett
Novel Microscopy Methodology to Examine DNA Damage Signaling and Repair. Brian T Bennett
Heterochromatin Formation in Fission Yeast. M Huarte, Yang Shi
Anti-fi brotic Property of CTGF siRNA in the Liver via Targeted Delivery to Hepatic Stellate Cells. David Roger Brigstock, C Lawrencia
Mallory Body Formation in the Livers of Drug-primed Mice Is Regulated by an Epigenetic Mechanism Jian Li
Myosin-activated Random Stress Fluctuations in the Actin Cytoskeleton David Weitz
Cytoplasmic Dynein Is a Better Navigator than Kinesin on Tau-decorated Microtubules. J. L. Ross
Determining the Molecular Architectures of Cellular Machines by Satisfaction of Spatial Restraints: The Nuclear Pore Complex. Adrian Salic
Posters Displayed:Monday Joan Brugge
Amaxa GmbH: Alan D Andrea
Post-Cytokinetic DNA Segregation by ATPases That Form DNA-Conducting Channels Tom A Rapoport, N L Sullivan, K Marquis
Maintenance of Polarity and Cell Shape in Vibrio cholerae Matthew K Waldor
Biochemical Characterization of Type III-secreted Bacterial Acetyltransferases J Orth
November 29, 2007 Cell Signalling and Novel Cancer Therapeutics mTOR signalling and oncogenesis John Blenis
Title (to be confirmed) George Daniel Demetri
November 27, 2007 Chromatin Structure & Function 2007 Role of the INO80 chromatin remodeling enzyme in DNA damage and DNA replication checkpoint responses Craig L Peterson
Sequencing the mammalian epigenome Brad Bernstein
TBC Kevin Struhl
November 15, 2007 2007 Fourth International Conference 1. Models of Integrative Oncology Programs Panel David S. Rosenthal
1. Models of Integrative Oncology Programs Panel David S. Rosenthal
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 11: Anti-Infectious Drug Discovery & Development (II) (09:00-12:20) Irene Bosch
Session 11: Identification of Novel and Effective Antiviral Treatment and zstablishment of Disease Pathogenesis: A journey of Global Gene Expression of dengue virus infection (11:20-11:40) Irene Bosch
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Plenary Session 2: Proteomics, Genomics and Biomarker Discovery Gregory L Verdine
Plenary Session 6: Clinical Intervention and Populations Outcomes: Global Strategies Rakesh K Jain
November 4, 2007 2007 International Symposium On Protein Modification And Degradation Discovery of thymus-specific proteasomes “thymoproteasomes” that regulate the development of CD8+T cells Daniel Finley, Alfred L. Goldberg
Session 3: Protein Modification by Non-ubiquitin/ubiquitin-like Proteins and Proteolysis Xi He, Kun Ping Lu
he Wisdom of Ubiquitination: Fine Control from Sloppy Chemistry. E Marco
Autophagy enhances the clearance of intracytosolic aggregate-prone proteins - therapeutic implications Tom A Rapoport
Session 6: Protein Modification, Proteolysis and Diseases Junying Yuan
Session 7: Protein Modification, Proteolysis and Drug Targets Kenneth Rock
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) Genome Resequencing for Mutation Screening (13:30-18:30) Raphael Bueno
Genome Resequencing for Mutation Screening: Deep Genomic Analysis of Tumors for the Discovery of Sequence Variation: From the Surgical Suite to the Genome Sequencer (16:30-17:00) Raphael Bueno
Next-Next Generation Sequencing (10:30-12:00) Jonathan Seidman
Next-Next Generation Sequencing: Polony Multiplex Analysis of Gene Expression (PMAGE) and Mouse Hypertrophic Cardiomyopathy (11:20-11:45) Jonathan Seidman
October 17, 2007 Second Annual Ion Channels: An Emerging Target for Therapeutic Development Oct (17-18) TARGETING PAIN MANAGEMENT: TRP Channels as Drug Targets (14:30-15:00) David E. Clapham
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi as a Predictive Tool (14:20-15:25) Yaakov Benenson
RNAi as a Predictive Tool: RNAi-Based Molecular Logic Circuits (14:55-15:25) Yaakov Benenson
RNAi FOR IN VIVO TARGET VALIDATION: In Vivo Imaging of siRNA Delivery and Silencing in Tumors (17:00-17:30) Anna Moore
October 15, 2007 Thirs Annual Quantitative PCR, MicroArrays, And Biologican Validation: Capturing the Complete Biological Story (Oct 15-17) Genetic Variation vs Gene Expression (14:00-19:00) George H. Perry
Genetic Variation vs Gene Expression: Detection and Characterization of Copy Number Variation in the Human Genome Using Array-Based Comparative Genomic Hybridization (16:00-16:30) George H. Perry
October 1, 2007 Barcelona BioMed Conferences: STEM CELLS AND CANCER Session I: Stem cells and their niches - I (09:15 - 12:45) Bruce A. Morgan
Stem cells and their niches - I (09:50 - 10:25) Bruce A. Morgan
Session IV: Cancer stem cells - I (14:30-18:20) Nuria de la Iglesia
Session IV: Cancer stem cells - I (16:00 -16:20) Nuria de la Iglesia
September 30, 2007 Bridging Pharma and IT - Leveraging Information Technology to Improve Productivity (Sep30-Oct2) BRIDGING CLINICAL AND IT (09:30-15:30) Samuel (Sandy) Aronson, Heidi Rehm
BRIDGING CLINICAL AND IT: IT Support for the Clinical Use of Genetics and Genomics – Could the Infrastructure in Place Today Be Strengthened through Collaborations with Pharma IT Departments? (11:45-12:30) Samuel (Sandy) Aronson, Heidi Rehm
September 7, 2007 The 2007 Breast Symposium The Impact of Local Treatment on Long-Term Survival: Local Control Matters Jay R Harris, MD
Premalignant Lesions: Ductal Carcinoma in Situ, Lobular Carcinoma in Situ, and Other Lesions that Increase the Risk of Invasive Breast Cancer Laura C. Collins
Is Axillary Dissection Needed in Node (+) Breast Cancer? Mehra Golshan
Is There an Optimal Way of Integrating Postmastectomy Radiation Therapy and Reconstruction? Abram Recht
August 11, 2007 Growth factor receptor tyrosine kinases in mitogenesis, morphogenesis Morphogenesis and oncogenesis in 3D breast epithelial cell cultures Joan Brugge
August 11, 2007 Lipid signaling Pathways in Cancer PI 3-kinase in cancer Lewis Cantley
Differential regulation of breast cancer cell invasive migration by Akt isoforms Rebecca Chin
July 28, 2007 Nutritional Immunology: Its Role in Health and Disease Cholesterol-sensitive signaling pathways in cancer Michael R Freeman
Probiotics and gut associated immune response Allen Walker
Micronutrient modulation of the progression of HIV infection in adults and children Saurabh Mehta
Dietary enhancement of human gamma delta T cell function with a defined mixture of green tea molecules correlates with prevention of cold and flu symptoms Jake Bukowski
July 21, 2007 Hematopoietic Malignancies Stem cell interactions with the microenvironment David T Scadden
Identification and characterization leukemic stem cells in the Li Chai
Transcription factors and myeloid leukemia Daniel G Tenen
GATA-1, Trisomy 21, and M7 Leukemia Stuart Orkin
FBW7 Mutations in Leukemic Cells Mediate NOTCH Pathway Activation and Resistance to gamma-Secretase Inhibitors Thomas A. Look
Context depended role of LRF/Pokemon in Oncogenesis” Pier Paolo
The Fanconi Anemia/BRCA pathway and the DNA damage response Alan D Andrea
DNA Breaks, End-joining Pathways, Translocations, and Lymphoma Frederick Alt
The Role of JAK2 Activation in the Pathogenesis and Treatment of Myeloproliferative Disorders Ross Levine
July 14, 2007 BIOLOGY OF CALPAINS IN HEALTH AND DISEASE Role of calpains and the proteasome in muscle wasting Alfred L. Goldberg
July 14, 2007 Skeletal Muscle Satellite & Stem Cells In Vivo Fluorescence Imaging of Muscle Regeneration By Transplanted EGFP-Labeled Myoblasts Yaming Wang
July 7, 2007 CHROMATIN AND TRANSCRIPTION The chicken-and-egg relationship between transcription and chromatin structure Kevin Struhl
Analysis of the SAGA, Swi/Snf, and RSC complexes from S. pombe Fred Winston
Possible roles in silencing for piRNAs Bob Kingston
Complex interactions at the X-inactivation center Jeanie Lee
Histone H3-K56 acetylation is catalyzed by histone chaperonedependent complexes Paul Kaufman
July 7, 2007 Protein Kinases and Protein Phosphorylation Signal transduction by Stress-activated MAP Kinases Roger Davis
ERK2 signaling through DEF domain interactions induces epithelial-to-mesenchymal transition (EMT) in breast epithelial cells Christopher Dimitri
Regulation of neuronal death by protein kinase pathways Azad Bonni
June 16, 2007 Nuclear Structure and Cancer Organization of transcriptional regulatory machinery in nuclear microenvironments: Implications for Biological Control and Cancer Gary S Stein
June 16, 2007 Thrombospondins and other Matricellular Proteins In Tissue Organization and Homeostasis Receptors and Cellular Networks Jack Lawler
Thrombospondin-1 affects the organization and function of endothelial cell membrane proteins Jack Lawler
Mechanisms of thrombospondin-1-mediated apoptosis Roya Khosravi Far
Regional endogenous anti-angiogenesis Judah Folkman
June 9, 2007 Ion Channel Regulation Regulation of spontaneous firing in mammalian central neurons Bruce Bean
June 9, 2007 Mitosis: Spindle Assembly and Function Cell cycle progression and de novo centriole assembly after centrosomal removal in untransformed human cells Kip Sluder
motion of chromosomes in cells lacking TPX2 Patricia Wadsworth
P31comet dynamics and mitotic checkpoint control Jagesh Shah
June 9, 2007 Transport ATPases: Structure, Mechanisms, Genomics and Disease Na,K-ATPase as a signal transducer Sunney Xie
Cellular dynamics of FXYD proteins, regulators of Na,K-ATPase Elena Arystarkhova
Trafficking regulation of the V-ATPase in specialized cells of the kidney and epididymis” Sylvie Breton
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.